In our latest study, conducted among consecutive patients with ovarian cancer from the Podkarpacie region (South-Eastern Poland), we observed only 6.3% BRCA1 or BRCA2 founder mutation carriers, and a slightly different spectrum of these mutations than in other regions of Poland [9]. Here, BRCA2 is linked to ovarian cancer.